96 related articles for article (PubMed ID: 21309408)
41. The detection of quantitative serum p53 protein in lung cancer.
Sen E; Gönüllü U; Akar N
Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
[TBL] [Abstract][Full Text] [Related]
42. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.
Forslund A; Engarås B; Lönnroth C; Lundholm K
Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598
[TBL] [Abstract][Full Text] [Related]
43. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients.
Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
Hepatogastroenterology; 2003; 50(51):696-9. PubMed ID: 12828063
[TBL] [Abstract][Full Text] [Related]
44. Oxidative stress and tumor progression in colorectal cancer.
Inokuma T; Haraguchi M; Fujita F; Tajima Y; Kanematsu T
Hepatogastroenterology; 2009; 56(90):343-7. PubMed ID: 19579595
[TBL] [Abstract][Full Text] [Related]
45. Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas.
Forslund A; Kressner U; Lindmark G; Inganäs M; Lundholm K
Int J Oncol; 2001 Sep; 19(3):501-6. PubMed ID: 11494027
[TBL] [Abstract][Full Text] [Related]
46. [The clinical significance of serum anti-p53 antibody as a monitoring marker in colorectal cancer].
Amano K; Kumamoto K; Kuwabara K; Ishiguro T; Ohsawa T; Okada N; Kumagai Y; Baba H; Ishibashi K; Tsuji Y; Haga N; Ishida H
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2170-2. PubMed ID: 23268013
[TBL] [Abstract][Full Text] [Related]
47. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
48. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
[TBL] [Abstract][Full Text] [Related]
49. Preoperative serum carbohydrate antigen 242 is a useful predictive and prognostic marker in colorectal cancer.
Yang XQ; Chen C; Hou JX; Peng CW; Huang CQ; Li Y
Hepatogastroenterology; 2011; 58(106):377-82. PubMed ID: 21661399
[TBL] [Abstract][Full Text] [Related]
50. [Clinical significance of serum anti-p53 antibody measurement for colorectal cancer].
Kuwabara K; Kumamoto K; Ishibashi K; Ohsawa T; Kumagai Y; Baba H; Tsuji Y; Haga N; Ishida H
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2167-9. PubMed ID: 23268012
[TBL] [Abstract][Full Text] [Related]
51. Elevated C-reactive protein level is associated with the tumor depth of invasion in patients with operable colorectal carcinoma.
Fujii T; Tabe Y; Yajima R; Yamaguchi S; Tsutsumi S; Asao T; Kuwano H
Hepatogastroenterology; 2011; 58(110-111):1470-3. PubMed ID: 22086684
[TBL] [Abstract][Full Text] [Related]
52. Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma.
Shimada H; Shiratori T; Takeda A; Matsushita K; Okazumi S; Akutsu Y; Matsubara H; Nomura F; Ochiai T
World J Surg; 2009 Feb; 33(2):272-7. PubMed ID: 19052812
[TBL] [Abstract][Full Text] [Related]
53. Hypoxia related growth factors and p53 in preoperative sera from patients with colorectal cancer--evaluation of the prognostic significance of these agents.
Sulkowski S; Wincewicz A; Zalewski B; Famulski W; Lotowska JM; Koda M; Sobaniec-Lotowska ME; Mysliwiec M; Baltaziak M; Pawlak K; Sulkowska M
Clin Chem Lab Med; 2009; 47(11):1439-45. PubMed ID: 19817649
[TBL] [Abstract][Full Text] [Related]
54. Human neutrophil peptides 1, 2 and 3 (HNP 1-3): elevated serum levels in colorectal cancer and novel marker of lymphatic and hepatic metastasis.
Kemik O; Kemik AS; Sumer A; Begenik H; Purisa S; Tuzun S
Hum Exp Toxicol; 2013 Feb; 32(2):167-71. PubMed ID: 21669914
[TBL] [Abstract][Full Text] [Related]
55. Circulating anti-p53 antibodies in esophageal cancer patients.
Kozłowski M; Kovalchuk O; Nikliński J; Chyczewski L; Starosławska E; Ciechański A; Dabrowski A; Niklińska W; Dziegielewski P; Lapuć G; Wallner G; Laudański J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():173-4. PubMed ID: 11820593
[TBL] [Abstract][Full Text] [Related]
56. Serum p53 antibodies as a prognostic indicator in oral squamous cell carcinoma.
Yamazaki Y; Chiba I; Ishikawa M; Satoh C; Notani K; Ohiro Y; Totsuka Y; Mizuno S; Kitagawa Y
Odontology; 2008 Jul; 96(1):32-7. PubMed ID: 18661202
[TBL] [Abstract][Full Text] [Related]
57. Humoral response to p53 in human colorectal tumors: a prospective study of 1,209 patients.
Tang R; Ko MC; Wang JY; Changchien CR; Chen HH; Chen JS; Hsu KC; Chiang JM; Hsieh LL
Int J Cancer; 2001 Dec; 94(6):859-63. PubMed ID: 11745489
[TBL] [Abstract][Full Text] [Related]
58. Changes of serum p53 antibodies and clinical significance of radiotherapy for esophageal squamous cell carcinoma.
Cai HY; Wang XH; Tian Y; Gao LY; Zhang LJ; Zhang ZY
World J Gastroenterol; 2008 Jul; 14(25):4082-6. PubMed ID: 18609695
[TBL] [Abstract][Full Text] [Related]
59. A reverse-ELISA for the detection of TRIM28/KAP1 serum autoantibodies in colorectal cancer patients.
Hector S; Chen H; Kijanka G; Murray F; Prehn JH
Acta Oncol; 2012 Mar; 51(3):394-6. PubMed ID: 22268577
[No Abstract] [Full Text] [Related]
60. Secreted recombinant P53 protein from Pichia pastoris is a useful antigen for detection of serum p53: autoantibody in patients with advanced colorectal adenocarcinoma.
Abdelmoula-Souissi S; Zouari N; Miladi-Abdenadher I; Yaich-Kolsi O; Ayadi-Masmoudi I; Khabir A; Masmoudi H; Frikha M; Mokdad-Gargouri R
Mol Biol Rep; 2013 May; 40(5):3865-72. PubMed ID: 23526366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
